Scott J Moeller1, Anna B Konova2, Muhammad A Parvaz1, Dardo Tomasi3, Richard D Lane4, Carolyn Fort4, Rita Z Goldstein1. 1. Department of Psychiatry, Icahn School of Medicine at Mount Sinai, New York, New York. 2. Department of Psychiatry, Icahn School of Medicine at Mount Sinai, New York, New York2Department of Psychology, Stony Brook University, Stony Brook, New York. 3. National Institute on Alcohol Abuse and Alcoholism, Bethesda, Maryland. 4. Department of Psychiatry, University of Arizona, Tucson.
Abstract
IMPORTANCE: Individuals with cocaine use disorder (CUD) have difficulty monitoring ongoing behavior, possibly stemming from dysfunction of brain regions mediating insight and self-awareness. OBJECTIVE: To investigate the neural correlates of impaired insight in addiction using a combined functional magnetic resonance imaging and voxel-based morphometry approach. DESIGN, SETTING, AND PARTICIPANTS: This multimodal imaging study was performed at the Clinical Research Center at Brookhaven National Laboratory. The study included 33 CUD cases and 20 healthy controls. MAIN OUTCOMES AND MEASURES: Functional magnetic resonance imaging, voxel-based morphometry, Levels of Emotional Awareness Scale, and drug use variables. RESULTS: Compared with the other 2 study groups, the impaired insight CUD group had lower error-induced rostral anterior cingulate cortex (rACC) activity as associated with more frequent cocaine use, less gray matter within the rACC, and lower Levels of Emotional Awareness Scale scores. CONCLUSIONS AND RELEVANCE: These results point to rACC functional and structural abnormalities and diminished emotional awareness in a subpopulation of CUD cases characterized by impaired insight. Because the rACC has been implicated in appraising the affective and motivational significance of errors and other types of self-referential processing, functional and structural abnormalities in this region could result in lessened concern (frequently ascribed to minimization and denial) about behavioral outcomes that could potentially culminate in increased drug use. Treatments that target this CUD subgroup could focus on enhancing the salience of errors (eg, lapses).
IMPORTANCE: Individuals with cocaine use disorder (CUD) have difficulty monitoring ongoing behavior, possibly stemming from dysfunction of brain regions mediating insight and self-awareness. OBJECTIVE: To investigate the neural correlates of impaired insight in addiction using a combined functional magnetic resonance imaging and voxel-based morphometry approach. DESIGN, SETTING, AND PARTICIPANTS: This multimodal imaging study was performed at the Clinical Research Center at Brookhaven National Laboratory. The study included 33 CUD cases and 20 healthy controls. MAIN OUTCOMES AND MEASURES: Functional magnetic resonance imaging, voxel-based morphometry, Levels of Emotional Awareness Scale, and drug use variables. RESULTS: Compared with the other 2 study groups, the impaired insight CUD group had lower error-induced rostral anterior cingulate cortex (rACC) activity as associated with more frequent cocaine use, less gray matter within the rACC, and lower Levels of Emotional Awareness Scale scores. CONCLUSIONS AND RELEVANCE: These results point to rACC functional and structural abnormalities and diminished emotional awareness in a subpopulation of CUD cases characterized by impaired insight. Because the rACC has been implicated in appraising the affective and motivational significance of errors and other types of self-referential processing, functional and structural abnormalities in this region could result in lessened concern (frequently ascribed to minimization and denial) about behavioral outcomes that could potentially culminate in increased drug use. Treatments that target this CUD subgroup could focus on enhancing the salience of errors (eg, lapses).
Authors: L M Shin; D D Dougherty; S P Orr; R K Pitman; M Lasko; M L Macklin; N M Alpert; A J Fischman; S L Rauch Journal: Biol Psychiatry Date: 2000-07-01 Impact factor: 13.382
Authors: Scott J Moeller; Thomas Maloney; Muhammad A Parvaz; Jonathan P Dunning; Nelly Alia-Klein; Patricia A Woicik; Greg Hajcak; Frank Telang; Gene-Jack Wang; Nora D Volkow; Rita Z Goldstein Journal: Biol Psychiatry Date: 2009-04-09 Impact factor: 13.382
Authors: Karen D Ersche; Anna Barnes; P Simon Jones; Sharon Morein-Zamir; Trevor W Robbins; Edward T Bullmore Journal: Brain Date: 2011-06-20 Impact factor: 13.501
Authors: Andy C Dean; Milky Kohno; Angelica M Morales; Dara G Ghahremani; Edythe D London Journal: Drug Alcohol Depend Date: 2015-03-18 Impact factor: 4.492
Authors: Anne S Berry; Robert L White; Daniella J Furman; Jenna R Naskolnakorn; Vyoma D Shah; Mark D'Esposito; William J Jagust Journal: J Neurosci Date: 2019-02-08 Impact factor: 6.167
Authors: Scott J Moeller; Anna B Konova; Dardo Tomasi; Muhammad A Parvaz; Rita Z Goldstein Journal: Psychopharmacology (Berl) Date: 2016-05-06 Impact factor: 4.530
Authors: Kyla D Gibney; George Kypriotakis; Paul M Cinciripini; Jason D Robinson; Jennifer A Minnix; Francesco Versace Journal: Psychophysiology Date: 2019-10-14 Impact factor: 4.016
Authors: Federica Lucantonio; Yuji K Takahashi; Alexander F Hoffman; Chun Yun Chang; Sheena Bali-Chaudhary; Yavin Shaham; Carl R Lupica; Geoffrey Schoenbaum Journal: Nat Neurosci Date: 2014-07-20 Impact factor: 24.884
Authors: Scott J Moeller; Stephen M Fleming; Gabriela Gan; Anna Zilverstand; Pias Malaker; Federico d'Oleire Uquillas; Kristin E Schneider; Rebecca N Preston-Campbell; Muhammad A Parvaz; Thomas Maloney; Nelly Alia-Klein; Rita Z Goldstein Journal: Eur Neuropsychopharmacol Date: 2016-02-10 Impact factor: 4.600